CERK and cancer: Chronic inflammation is a well-known risk factor for cancer development and, in view of our previous findings that the metastatic sublines 4175 and 1833 produce much higher amounts of PGE2 [26] and that cPLA2 is implicated in breast cancer cell migration [35,36], it is plausible that the pro-migratory effect of CerK/C1P involves cPLA2.